If you're considering a medication transition, integrating genetic context into your provider conversation can support a more evidence-based decision
Additional Adverse Effects Recently Identified Other studies show that GLP-1 meds cause loss of muscle mass
While generally well-tolerated, clinicians must be mindful of risks such as hypoglycemia, bradycardia, hypotension, and bronchospasm, particularly in infants and patients with comorbid cardiopulmonary disease
Your GP may want to monitor your blood levels more frequently when you first start semaglutide to see if your dose needs adjusting
Hers used to offer compounded GLP-1 medications, but recently, they have discontinued them and only sell the name brands, created by Eli Lilly and Novo Nordisk (for now)
doi: 10.1038/s41591-019-0512-5 85 HeplerCShanBZhangQHenryGHShaoMVishvanathLet al